Anderson KC - Search Results

1

beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells.

Gupta D, Podar K, Tai YT, Lin B, Hideshima T, Akiyama M, LeBlanc R, Catley L, Mitsiades N, Mitsiades C, Chauhan D, Munshi NC, Anderson KC. Gupta D, et al. Among authors: anderson kc. Exp Hematol. 2002 Jul;30(7):711-20. doi: 10.1016/s0301-472x(02)00839-1. Exp Hematol. 2002. PMID: 12135668 Free article.

2

Advances in the biology of multiple myeloma: therapeutic applications.

Anderson K. Anderson K. Semin Oncol. 1999 Oct;26(5 Suppl 13):10-22. Semin Oncol. 1999. PMID: 10528890 Review.

3

Tumor Cell Expression of CD59 Is Associated With Resistance to CD20 Serotherapy in Patients With B-Cell Malignancies.

Treon SP, Mitsiades C, Mitsiades N, Young G, Doss D, Schlossman R, Anderson KC. Treon SP, et al. Among authors: anderson kc. J Immunother (1991). 2001 May;24(3):263-271. J Immunother (1991). 2001. PMID: 11395643

4

Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation.

Podar K, Tai YT, Lin BK, Narsimhan RP, Sattler M, Kijima T, Salgia R, Gupta D, Chauhan D, Anderson KC. Podar K, et al. Among authors: anderson kc. J Biol Chem. 2002 Mar 8;277(10):7875-81. doi: 10.1074/jbc.M109068200. Epub 2001 Dec 20. J Biol Chem. 2002. PMID: 11751905 Free article.

5

CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cells.

Tai YT, Podar K, Gupta D, Lin B, Young G, Akiyama M, Anderson KC. Tai YT, et al. Among authors: anderson kc. Blood. 2002 Feb 15;99(4):1419-27. doi: 10.1182/blood.v99.4.1419. Blood. 2002. PMID: 11830495 Free article.

6

Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays.

Chauhan D, Auclair D, Robinson EK, Hideshima T, Li G, Podar K, Gupta D, Richardson P, Schlossman RL, Krett N, Chen LB, Munshi NC, Anderson KC. Chauhan D, et al. Among authors: anderson kc. Oncogene. 2002 Feb 21;21(9):1346-58. doi: 10.1038/sj.onc.1205205. Oncogene. 2002. PMID: 11857078

7

NF-kappa B as a therapeutic target in multiple myeloma.

Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, Hayashi T, Munshi N, Dang L, Castro A, Palombella V, Adams J, Anderson KC. Hideshima T, et al. Among authors: anderson kc. J Biol Chem. 2002 May 10;277(19):16639-47. doi: 10.1074/jbc.M200360200. Epub 2002 Feb 28. J Biol Chem. 2002. PMID: 11872748 Free article.

8

Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells.

Mitsiades N, Mitsiades CS, Poulaki V, Anderson KC, Treon SP. Mitsiades N, et al. Among authors: anderson kc. Blood. 2002 Mar 15;99(6):2162-71. doi: 10.1182/blood.v99.6.2162. Blood. 2002. PMID: 11877293 Free article.

9

Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implications.

Tai YT, Podar K, Kraeft SK, Wang F, Young G, Lin B, Gupta D, Chen LB, Anderson KC. Tai YT, et al. Among authors: anderson kc. Exp Hematol. 2002 Mar;30(3):212-20. doi: 10.1016/s0301-472x(01)00786-x. Exp Hematol. 2002. PMID: 11882358 Free article.

10

CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications.

Treon SP, Pilarski LM, Belch AR, Kelliher A, Preffer FI, Shima Y, Mitsiades CS, Mitsiades NS, Szczepek AJ, Ellman L, Harmon D, Grossbard ML, Anderson KC. Treon SP, et al. Among authors: anderson kc. J Immunother. 2002 Jan-Feb;25(1):72-81. doi: 10.1097/00002371-200201000-00008. J Immunother. 2002. PMID: 11924912 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,221 results

Search Page

Filters